Day & Ennis’s Abiomed Inc ABMD Stock Holding History

Day & Ennis’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-4,000	Closed	-$361K	–	69
2015 Q4	$361K	Buy	+4,000	New	+$339K	0.4%	38

Other funds holding ABMD

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Day & Ennis's ABMD Position: Q1 2016 in Review

Day & Ennis sold out of Abiomed Inc (ABMD) in Q1 2016, closing a stake of 4,000 shares — an estimated $361K sold.

Day & Ennis first reported a position in ABMD in Q4 2015 and held it in 1 quarter. The position peaked at $361K in Q4 2015. 274 funds tracked by Wall St. Rank hold ABMD as of Q1 2016.

Day & Ennis reported no remaining Abiomed Inc position as of Q1 2016 after selling out during the quarter.
Day & Ennis sold 4,000 Abiomed Inc shares in Q1 2016, an estimated $361K.
Day & Ennis first reported a position in Abiomed Inc in Q4 2015 and held it in 1 quarter.
Day & Ennis's Abiomed Inc position peaked at $361K in Q4 2015.
274 funds tracked by Wall St. Rank held Abiomed Inc as of Q1 2016.

Based on Day & Ennis's 13F filing for Q1 2016, filed 16 Aug 2016.